ReportingMassachusetts
Fractyl Health in Burlington, Mass., to cut about 45% of its workforce

The biotech is narrowing its focus to Revita, a weight-maintenance procedure, and dropping internal work on a gene therapy program.
Published
Loading coverage...
Coverage of SEC filings from Six State Signal.

The biotech is narrowing its focus to Revita, a weight-maintenance procedure, and dropping internal work on a gene therapy program.